DISCOVERING DEVELOPING DELIVERING HOPE Trademark

Trademark Overview


On Thursday, November 8, 2018, a trademark application was filed for DISCOVERING DEVELOPING DELIVERING HOPE with the United States Patent and Trademark Office. The USPTO has given the DISCOVERING DEVELOPING DELIVERING HOPE trademark a serial number of 88186713. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by Mezzion Pharma Co., Ltd.. The DISCOVERING DEVELOPING DELIVERING HOPE trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues

Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes

Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the f...
discovering developing delivering hope

General Information


Serial Number88186713
Word MarkDISCOVERING DEVELOPING DELIVERING HOPE
Filing DateThursday, November 8, 2018
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6337607
Registration DateTuesday, May 4, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements


Goods and ServicesEducational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues
Description of MarkThe mark consists of stylized "DISCOVERING" "DEVELOPING" "DELIVERING HOPE" with a dot on either side of "DEVELOPING".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
NOT AVAILABLE"DISCOVERING DEVELOPING"
Goods and ServicesMedical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMezzion Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSeoul 06163
KR

Party NameMezzion Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeoul 06167
KR

Party NameMezzion Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeoul 06167
KR

Trademark Events


Event DateEvent Description
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 12, 2018NEW APPLICATION ENTERED
Wednesday, November 28, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 22, 2019ASSIGNED TO EXAMINER
Thursday, January 24, 2019NON-FINAL ACTION WRITTEN
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 29, 2019ASSIGNED TO LIE
Wednesday, July 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 2, 2019SUSPENSION LETTER WRITTEN
Friday, June 12, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 2, 2019LETTER OF SUSPENSION E-MAILED
Friday, August 2, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 10, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 10, 2020SUSPENSION INQUIRY WRITTEN
Monday, February 10, 2020INQUIRY TO SUSPENSION E-MAILED
Monday, February 10, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, June 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 30, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 30, 2020NON-FINAL ACTION E-MAILED
Tuesday, June 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 8, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, January 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2021ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, May 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS